Colin Huntley1, Jeniece Cooper2, Marlind Stiles3, Ritu Grewal4, Maurits Boon1. 1. Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania. 2. Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. 3. Department of Oral and Maxillofacial Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania. 4. Jefferson Sleep Disorders Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Abstract
STUDY OBJECTIVES: Oral appliance therapy (OAT) can be an effective treatment option for patients with obstructive sleep apnea unable to tolerate continuous positive airway pressure. We hypothesize that drug-induced sleep endoscopy (DISE) can be useful in identifying patients who will benefit from OAT. METHODS: A retrospective review of all patients who underwent DISE (DISE group) between January 2014 and June 2016 was carried out. We included patients if they received OAT based on recommendations made by DISE findings. A control group was designed by selecting a sample of patients undergoing polysomnography (PSG) with an oral appliance in place who had not undergone prior DISE (no DISE group). The two cohorts were compared to evaluate the hypothesis. RESULTS: A total of 20 patients fit inclusion criteria for the DISE group and 20 patients for the no DISE group. There was no difference between the DISE and no DISE cohorts with respect to mean age, sex, pre-OAT body mass index, post-OAT body mass index, or pre-OAT PSG characteristics including: apneahypopnea index (AHI), oxygen desaturation nadir, or Epworth Sleepiness Scale score. There was a significantly lower treatment AHI (P = .04) and increased number of patients reaching an AHI less than 5 events/h with OAT therapy (P = .04) in the DISE group. CONCLUSIONS: Patients showing increased airway dimensions at the level of the velum and/or oropharynx with a jaw thrust may benefit the most from OAT. The use of DISE to identify this subset of patients is helpful in optimizing outcomes with OAT.
STUDY OBJECTIVES: Oral appliance therapy (OAT) can be an effective treatment option for patients with obstructive sleep apnea unable to tolerate continuous positive airway pressure. We hypothesize that drug-induced sleep endoscopy (DISE) can be useful in identifying patients who will benefit from OAT. METHODS: A retrospective review of all patients who underwent DISE (DISE group) between January 2014 and June 2016 was carried out. We included patients if they received OAT based on recommendations made by DISE findings. A control group was designed by selecting a sample of patients undergoing polysomnography (PSG) with an oral appliance in place who had not undergone prior DISE (no DISE group). The two cohorts were compared to evaluate the hypothesis. RESULTS: A total of 20 patients fit inclusion criteria for the DISE group and 20 patients for the no DISE group. There was no difference between the DISE and no DISE cohorts with respect to mean age, sex, pre-OAT body mass index, post-OAT body mass index, or pre-OAT PSG characteristics including: apneahypopnea index (AHI), oxygen desaturation nadir, or Epworth Sleepiness Scale score. There was a significantly lower treatment AHI (P = .04) and increased number of patients reaching an AHI less than 5 events/h with OAT therapy (P = .04) in the DISE group. CONCLUSIONS:Patients showing increased airway dimensions at the level of the velum and/or oropharynx with a jaw thrust may benefit the most from OAT. The use of DISE to identify this subset of patients is helpful in optimizing outcomes with OAT.
Authors: Michiel H J Doff; Aarnoud Hoekema; Peter J Wijkstra; Johannes H van der Hoeven; James J R Huddleston Slater; Lambert G M de Bont; Boudewijn Stegenga Journal: Sleep Date: 2013-09-01 Impact factor: 5.849
Authors: Waqas T Qureshi; Usama Bin Nasir; Shehabaldin Alqalyoobi; Wesley T O'Neal; Sagar Mawri; Salah Sabbagh; Elsayed Z Soliman; Mouaz H Al-Mallah Journal: Am J Cardiol Date: 2015-09-12 Impact factor: 2.778
Authors: Chloé Kastoer; Marijke Dieltjens; Eline Oorts; Evert Hamans; Marc J Braem; Paul H Van de Heyning; Olivier M Vanderveken Journal: J Clin Sleep Med Date: 2016-10-15 Impact factor: 4.062
Authors: Kentaro Okuno; Yasuhiro Sasao; Kanji Nohara; Takayoshi Sakai; Benjamin T Pliska; Alan A Lowe; C Frank Ryan; Fernanda R Almeida Journal: Eur Respir J Date: 2016-01-07 Impact factor: 16.671
Authors: Crystal Sj Cheong; Weiqiang Loke; Mark Kim Thye Thong; Song Tar Toh; Chi-Hang Lee Journal: Clin Exp Otorhinolaryngol Date: 2020-10-16 Impact factor: 3.372